120 related articles for article (PubMed ID: 8622889)
1. Delay in serum stimulation of Erk activity caused by oncogenic transformation.
Greulich H; Reichman C; Hanafusa H
Oncogene; 1996 Apr; 12(8):1689-95. PubMed ID: 8622889
[TBL] [Abstract][Full Text] [Related]
2. Repression of mitogen-activated protein kinases ERK1/ERK2 activity by a protein tyrosine phosphatase in rat fibroblasts transformed by upstream oncoproteins.
Gopalbhai K; Meloche S
J Cell Physiol; 1998 Jan; 174(1):35-47. PubMed ID: 9397154
[TBL] [Abstract][Full Text] [Related]
3. Suppression of growth factor-mediated MAP kinase activation by v-raf in macrophages: a putative role for the MKP-1 phosphatase.
Krautwald S; Büscher D; Dent P; Ruthenberg K; Baccarini M
Oncogene; 1995 Mar; 10(6):1187-92. PubMed ID: 7700643
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase.
Groom LA; Sneddon AA; Alessi DR; Dowd S; Keyse SM
EMBO J; 1996 Jul; 15(14):3621-32. PubMed ID: 8670865
[TBL] [Abstract][Full Text] [Related]
5. Control of MAP kinase activation by the mitogen-induced threonine/tyrosine phosphatase PAC1.
Ward Y; Gupta S; Jensen P; Wartmann M; Davis RJ; Kelly K
Nature; 1994 Feb; 367(6464):651-4. PubMed ID: 8107850
[TBL] [Abstract][Full Text] [Related]
6. A role for Ras in v-Crk transformation.
Greulich H; Hanafusa H
Cell Growth Differ; 1996 Nov; 7(11):1443-51. PubMed ID: 8930393
[TBL] [Abstract][Full Text] [Related]
7. Mitogen-activated protein kinase and mitogen-activated kinase phosphatase-1 expression in the Noble rat model of sex hormone-induced prostatic dysplasia and carcinoma.
Leav I; Galluzzi CM; Ziar J; Stork PJ; Ho SM; Loda M
Lab Invest; 1996 Sep; 75(3):361-70. PubMed ID: 8804359
[TBL] [Abstract][Full Text] [Related]
8. Asbestos causes stimulation of the extracellular signal-regulated kinase 1 mitogen-activated protein kinase cascade after phosphorylation of the epidermal growth factor receptor.
Zanella CL; Posada J; Tritton TR; Mossman BT
Cancer Res; 1996 Dec; 56(23):5334-8. PubMed ID: 8968079
[TBL] [Abstract][Full Text] [Related]
9. Transformation-resistant mos revertant is unable to activate MAP kinase kinase in response to v-mos or v-raf.
Topol LZ; Marx M; Calothy G; Blair DG
Cell Growth Differ; 1995 Jan; 6(1):27-38. PubMed ID: 7718484
[TBL] [Abstract][Full Text] [Related]
10. Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation.
Hutter D; Chen P; Barnes J; Liu Y
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):155-63. PubMed ID: 11062068
[TBL] [Abstract][Full Text] [Related]
11. Disruption of the erp/mkp-1 gene does not affect mouse development: normal MAP kinase activity in ERP/MKP-1-deficient fibroblasts.
Dorfman K; Carrasco D; Gruda M; Ryan C; Lira SA; Bravo R
Oncogene; 1996 Sep; 13(5):925-31. PubMed ID: 8806681
[TBL] [Abstract][Full Text] [Related]
12. Extracellular signal-regulated kinase-2, but not c-Jun NH2-terminal kinase, activation correlates with surface IgM-mediated apoptosis in the WEHI 231 B cell line.
Lee JR; Koretzky GA
J Immunol; 1998 Aug; 161(4):1637-44. PubMed ID: 9712025
[TBL] [Abstract][Full Text] [Related]
13. Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade.
Lengyel E; Wang H; Gum R; Simon C; Wang Y; Boyd D
Oncogene; 1997 May; 14(21):2563-73. PubMed ID: 9191056
[TBL] [Abstract][Full Text] [Related]
14. The mitogen-activated protein kinases, ERK1 and ERK2.
Cobb MH; Hepler JE; Cheng M; Robbins D
Semin Cancer Biol; 1994 Aug; 5(4):261-8. PubMed ID: 7803762
[TBL] [Abstract][Full Text] [Related]
15. Serotonergic repression of mitogen-activated protein kinase control of the calcitonin gene-related peptide enhancer.
Durham PL; Russo AF
Mol Endocrinol; 1998 Jul; 12(7):1002-9. PubMed ID: 9658404
[TBL] [Abstract][Full Text] [Related]
16. Ecdysone-inducible expression of oncogenic Ha-Ras in NIH 3T3 cells leads to transient nuclear localization of activated extracellular signal-regulated kinase regulated by mitogen-activated protein kinase phosphatase-1.
Plows D; Briassouli P; Owen C; Zoumpourlis V; Garrett MD; Pintzas A
Biochem J; 2002 Mar; 362(Pt 2):305-15. PubMed ID: 11853538
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase.
Bedecs K; Elbaz N; Sutren M; Masson M; Susini C; Strosberg AD; Nahmias C
Biochem J; 1997 Jul; 325 ( Pt 2)(Pt 2):449-54. PubMed ID: 9230127
[TBL] [Abstract][Full Text] [Related]
18. Mek1 phosphorylation site mutants activate Raf-1 in NIH 3T3 cells.
Alessandrini A; Greulich H; Huang W; Erikson RL
J Biol Chem; 1996 Dec; 271(49):31612-8. PubMed ID: 8940180
[TBL] [Abstract][Full Text] [Related]
19. Activation of the mitogen-activated protein kinase pathway in U937 leukemic cells induces phosphorylation of the amino terminus of the TATA-binding protein.
Biggs JR; Ahn NG; Kraft AS
Cell Growth Differ; 1998 Aug; 9(8):667-76. PubMed ID: 9716183
[TBL] [Abstract][Full Text] [Related]
20. Bradykinin reduces growth factor-induced glomerular ERK1/2 phosphorylation.
Cellier E; Mage M; Duchêne J; Pécher C; Couture R; Bascands JL; Girolami JP
Am J Physiol Renal Physiol; 2003 Feb; 284(2):F282-92. PubMed ID: 12388422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
